Calculate your SIP ReturnsExplore

O H L VOL


Days Range

Data is not available currently. Please check back later.

Data is not available currently. Please check back later.

About Remus Pharmaceuticals

Remus Pharmaceuticals Limited was originally incorporated as Remus Pharmaceuticals Private Limited' as a private limited company, vide Certificate of Incorporation dated September 21, 2015, issued by the Assistant Registrar of Companies, Gujarat. Subsequently, Company converted from a private company to public company and consequently, the name of Company was changed to 'Remus Pharmaceuticals Limited' on January 06, 2023 by the Registrar of Companies, Ahmedabad. The Company is engaged in marketing & distribution of finished formulations of pharmaceutical drugs. It deals in API (Active Pharmaceutical Ingredient), provide technical consultancy services to various distributors for preparation of reports on the dossiers of the products to be registered by them in various countries. The Company deal in drug forms like Capsules, Cream, Eye Drops, Gel, Infusion, Inhalation, Inhaler, Injection, Nail Lacquer, Nasal Solution, Nasal Spray, Nebuliser, Ointment, Ophthalmic, Oral Gel, Oral Solution, Oral Suspension, Sachet, Suspension, Tablet. The core business of the Company into three categories, which comprise of Manufacturing, through loan licencse or on contract manufacturing bassis, of approved finished formulations and distribution of the same in various countries; Trading of Active Pharmaceutical Ingredients and Technical Consultancy on preparation of reports on pharmaceutical dossiers.The product portfolio comprises of therapeutic drugs like ACE inhibitors, anaesthetic, Anti histamine, Antifungal, Anti-inflammatory, Antibiotic, Antidiabetic, Antipsychotic, Antiretroviral, Chronic Obstructive Pulmonary Disease, Asthma, Carcinoid tumours, CNS stimulants, Nasal decongestants, Potassium deficiency, Probiotic, Antispasmodic, Ocular-hypertension, Urology and Vitamin deficiency. The Pharma business operations are supported by various contract manufacturers having facilities which are WHO GMP Compliant. The core strength lies in getting approved formulation manufactured through contract manufacturers under loan licence and marketing of formulations through marketing network across geographies.The product portfolio consists of 429 products, as on January 31, 2023. The Company has business to business supply agreements with 58 domestic distributors and 139 international distributors for distribution and/or contract manufacturing supply. The Company is proposing an initial public issue consisting of upto 388000 Equity Shares through Fresh Issue.

Parent Organisation
Indian Private
Managing Director
None
Founded
2015
NSE Symbol
REMUS

Peer Comparision

StocksMarket Cap (cr)Market Price (₹)52 Week Low-High (₹)

Community Discussion

A
AngelOne
10th July 2024
0 Likes
0 Replies

A
AngelOne
10th July 2024
Remus Pharmaceuticals Ltd-latest-market-updates-86530
0 Likes
0 Replies

Remus Pharmaceuticals Ltd FAQs

Remus Pharmaceuticals Ltd (REMUS) share price as of July 15, 2024, on NSE is Rs 1949.95 (NSE) and Rs 1949.95 (BSE) on BSE.
Yes, You can buy Remus Pharmaceuticals Ltd (REMUS) shares by opening a Demat account with Angel One.
Remus Pharmaceuticals Ltd (REMUS) share can be bought through the following modes:
1. Direct investment: You can buy Remus Pharmaceuticals Ltd (REMUS) shares by opening a Demat account with Angel One.
2. Indirect investment: The indirect method involves investing through ETFs and Mutual Funds that offer exposure to Remus Pharmaceuticals Ltd (REMUS) shares.
Open Free Demat Account!

Enjoy Zero Brokerage on Equity Delivery

Join our 2 Cr+ happy customers

+91
Top Stocks

VIEW ALLView All Stocks

Top Gainers





VIEW ALLView All Stocks

Top Losers





VIEW ALLView All Stocks

Enjoy Zero Brokerage on Equity Delivery
4.4 Cr+DOWNLOADS
Enjoy Zero Brokerage on Equity Delivery

Get the link to download the App

Send App Link
Open Free Demat Account!
Enjoy Zero Brokerage on Stock Investments.